SureTrader SureTrader
Home > Boards > US OTC > Delisted >

LegalLife Plans, Inc. (fka LLFP)

RSS Feed
Add Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board:
Last Post: 9/12/2016 9:33:38 AM - Followers: 9 - Board type: Free - Posts Today: 0

 Cancer Therapeutics Inc.


Cancer Therapeutics, Inc. is a biotechnology business incubator, with a specific emphasis on disruptive treatments and nanotechnology.  It seeks out disruptive cancer research and technology opportunities to invest in, develop, and commercialize.  The end result will be therapies, treatments, and pharmaceuticals targeted at more efficiently and effectively attacking cancer.  CTI seeks partners to co-develop drugs in various stages in our pipeline.

CTI’s first investment under this strategy is NanoTherapies LLC.  Nano’s products introduce disruptive technology into the treatment and detection of cancer through the use of calcium phosphate nanoparticles.  These particles, about 350 times smaller than a human cell, provide both a safe and effective way to transport drugs and imaging materials into diseased cells.  The compatibility of the calcium phosphate nanoparticle with the biomechanics of the human body makes it unique for application in the treatment of diseases.  Patient benefits from drugs jacketed with calcium phosphate nanoparticles are immense.

The development of these life-changing therapies for cancer treatment is achieved through an evolving set of intellectual properties and patents derived from the exploitation of calcium phosphate nanoparticles for therapeutic and diagnostic applications.  NanoTherapies has sole license and patent protection for the fundamental use of calcium phosphate nanoparticles in medical applications for the treatment and detection of blood cancers (all forms of leukemia).  Nano also owns all rights to manufacturing technologies and patents required to produce pharmaceutical quality drugs at the scale and yield needed for commercial viability.

Four drugs have been identified for accelerated market delivery and early revenue:  Methotrexate, Cytarabine, Fludarabine and Daunorubicin.  Cerimide-based drugs and a newly discovered Amplified Photon Emission Therapy (APET) also comprise part of the product portfolio, but will require longer clinical trials to get to market.
 Cancer Therapeutics, Inc. is a biotechnology business incubator, with a specific emphasis on disruptive treatments and nanotechnology.  It seeks out disruptive cancer research and technology opportunities to invest in, develop, and commercialize.  The end result will be therapies, treatments, and pharmaceuticals targeted at more efficiently and effectively attacking cancer.  CTI seeks partners to co-develop drugs in various stages in our pipeline.

CTI’s first investment under this strategy is NanoTherapies LLC.  Nano’s products introduce disruptive technology into the treatment and detection of cancer through the use of calcium phosphate nanoparticles.  These particles, about 350 times smaller than a human cell, provide both a safe and effective way to transport drugs and imaging materials into diseased cells.  The compatibility of the calcium phosphate nanoparticle with the biomechanics of the human body makes it unique for application in the treatment of diseases.  Patient benefits from drugs jacketed with calcium phosphate nanoparticles are immense.

The development of these life-changing therapies for cancer treatment is achieved through an evolving set of intellectual properties and patents derived from the exploitation of calcium phosphate nanoparticles for therapeutic and diagnostic applications.  NanoTherapies has sole license and patent protection for the fundamental use of calcium phosphate nanoparticles in medical applications for the treatment and detection of blood cancers (all forms of leukemia).  Nano also owns all rights to manufacturing technologies and patents required to produce pharmaceutical quality drugs at the scale and yield needed for commercial viability.

Four drugs have been identified for accelerated market delivery and early revenue:  Methotrexate, Cytarabine, Fludarabine and Daunorubicin.  Cerimide-based drugs and a newly discovered Amplified Photon Emission Therapy (APET) also comprise part of the product portfolio, but will require longer clinical trials to get to market.

Cancer Therapeutics will be in a position to engage high level personnel and intellectual capital from NanoTherapies to evaluate other synergistic investment opportunities.  CTI will then pursue the most promising and valuable technologies to reach the market expeditiously and benefit the lives of cancer patients worldwide.

Cancer Therapeutics Inc is a Delaware corporation.  CTI’s Common Stock is listed on the NASD Electronic Bulletin Board under the symbol “CTHP.”  The Company’s stock has been traded on the Bulletin Board since March, 2007.

Cancer Therapeutics Inc is located in South Jordan (Salt Lake City), Utah.


Cancer Therapeutics Inc
10757 S. River Front Pkwy.
Suite 125
South Jordan, Utah 84095
 
Telephone  (801) 816-2533
Facsimile  (801) 816-2599
Email

Chene Gardner
President, Chief Executive Officer, Chief Financial Officer

John D. Thomas
General Counsel

SEC Filings:  http://www.otcmarkets.com/stock/CTHP/financials

Outstanding Shares: 85,541,266 as of Sep 07, 2010


 

 

The information contained within this iBox including web links, copied information, and any other associated messages/media (hereinafter collectively referred to as "Information") is provided for informational purposes only. The Information should not be construed as investment/trading advice and is not meant to be a solicitation or recommendation to buy, sell, or hold Cancer Therapeutics, Inc.  (CTHP) stock.

PostSubject
#324   LLFP revoked: Renee 09/12/16 09:33:38 AM
#323   LLFP SEC Suspension for Financials / Filings delinquencies: Renee 08/09/16 09:36:09 AM
#322   This one will heat up again. RealGenius 07/27/14 02:17:20 PM
#321   TY RnR. Much appreciated. $oldier Hard 11/08/10 07:02:17 PM
#320   NDSI new ticker RACKnRICKY 11/08/10 11:44:51 AM
#319   Thx richboy. Was outta town. Only been back $oldier Hard 10/25/10 11:58:52 PM
#318   Too bad about the R/S this could have zen222 10/25/10 01:26:54 PM
#317   8-k out.. A/S increased to 500M. R/S effective richboy1 10/25/10 01:21:41 PM
#316   Probably just pump and dump, still no news... akeygon 10/25/10 01:14:52 PM
#315   500-1 R/S will do that S3lfMade 10/25/10 01:10:11 PM
#314   that was a quick drop RACKnRICKY 10/25/10 01:09:57 PM
#313   160% now! RACKnRICKY 10/25/10 01:04:03 PM
#312   8-k out.. A/S increased to 500M. R/S effective S3lfMade 10/25/10 01:03:38 PM
#311   Delaware filings for the name change. Might shed zen222 10/25/10 12:52:41 PM
#310   i see some presentations are up coming. what S3lfMade 10/25/10 12:50:39 PM
#309   .018's up zen222 10/25/10 12:49:12 PM
#308   hey guys. looking good here. whats the word? S3lfMade 10/25/10 12:45:25 PM
#307   .0149 x.015 Go CTHP !! uzo200 10/25/10 12:40:24 PM
#306   Just ordered the Delaware filings. Will post them tomorrow. zen222 10/25/10 12:34:44 PM
#305   Looks like this is our company: Zone Plates zen222 10/25/10 12:28:14 PM
#304   You might find this interesting: zen222 10/25/10 11:29:39 AM
#303   i still watching and kinda regretting not pulling RACKnRICKY 10/24/10 09:40:29 PM
#302   Nice chart for CTHP my good friend. TY $oldier Hard 10/24/10 06:22:47 PM
#301   CTHP ALiVE 10/24/10 05:41:34 PM
#300   Well they just filed a 10q this month $oldier Hard 10/24/10 11:18:14 AM
#299   i actually called the TA for share structure RACKnRICKY 10/22/10 09:09:51 PM
#298   absolutely $oldier Hard 10/22/10 09:02:32 PM
#297   did you buy some yesterday? RACKnRICKY 10/22/10 08:58:37 PM
#296   "IF" there was a catalyst of sorts to $oldier Hard 10/22/10 08:28:37 PM
#295   i was watching when it went to a RACKnRICKY 10/22/10 08:25:19 PM
#294   Last 3 days have been above avg 10 $oldier Hard 10/22/10 08:04:40 PM
#293   Bollinger Bands has closed below upper band by alhigou 10/22/10 07:34:05 PM
#292   only have this on watch,almost got in yesterday RACKnRICKY 10/22/10 07:22:43 PM
#291   Another solid volume day my friend. 3.38 times $oldier Hard 10/22/10 03:41:54 PM
#290   Hey buddy, doesn't seem to be dodgin you here. $oldier Hard 10/22/10 03:40:43 PM
#289   $0.0076 now, up (35.71%) zen222 10/22/10 03:13:34 PM
#288   .006 x .0074 now. Ask getting slapped. zen222 10/22/10 03:03:14 PM
#287   Apt post! Some solid made points S.H. I'm zen222 10/22/10 02:39:26 PM
#286   In for a starter, loving these prices .0055x.006 zen222 10/22/10 02:31:40 PM
#285   trying to make a buck somewhere.it keeps dodging me.lol RACKnRICKY 10/22/10 12:44:56 PM
#284   Personally I don't give a rats Azz if $oldier Hard 10/21/10 10:53:35 PM
#283   Some Volume?!?!? 15.5 times the avg 10 day. $oldier Hard 10/21/10 10:27:08 PM
#282   some vol today and the spread is alot RACKnRICKY 10/21/10 03:41:59 PM
#281   This is just a shell... with no interest Titun 10/21/10 03:02:38 PM
#280   Still watching. Avg 10 day volume 10,999. Today $oldier Hard 10/14/10 10:32:07 PM
#279   Avg 10 Day volume 38,613, yesterday 265,167 or $oldier Hard 09/25/10 01:29:19 PM
#278   Watchin you. 10 day avg volume 33,380, today $oldier Hard 09/21/10 09:19:48 PM
#277   Hmmmm, They did file the 10k Today A/Hs. $oldier Hard 09/14/10 10:14:36 PM
#276   oh wow! yep, i had beautiful timing on RACKnRICKY 08/12/10 11:23:28 PM
#275   I think EYSM, if I remember correctly. Kop 08/12/10 10:29:26 PM
PostSubject